A randomised, controlled, study in healthy adults to evaluate the safety and immunogenicity of an adjuvanted recombinant 2009 H1N1 pandemic swine influenza vaccine.

Trial Profile

A randomised, controlled, study in healthy adults to evaluate the safety and immunogenicity of an adjuvanted recombinant 2009 H1N1 pandemic swine influenza vaccine.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary) ; ADVAX
  • Indications Influenza A virus H1N1 subtype
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 29 Aug 2011 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
    • 18 Sep 2010 Results published as an abstract at the 20th Annual Congress of the European Respiratory Society (ERS).
    • 08 Aug 2009 Planned initiation date (13 Jul 2009) and official title added as reported by Australian New Zealand Clinical Trials Registry record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top